Philips expects to reach recall settlements this year: CEO Roy Jakobs

Published On 2023-04-02 06:30 GMT   |   Update On 2023-04-02 06:30 GMT
Advertisement

Amsterdam: Dutch health technology company Philips expects to reach settlements this year relating to its global recall of respiratory devices, CEO Roy Jakobs said in an interview with Dutch financial daily FD published on Thursday.

"I think we can at least reach a settlement on economic damages this year," Jakobs said without giving details on the expected costs.
Jakobs added he "hopes and expects" to also reach a settlement with the US Food and Drug Administration this year. A settlement with patients who claim the use of the recalled machines made them sick probably will take longer, he said.
A spokesperson for Philips confirmed the quotations in the newspaper were accurate. Shares in the Amsterdam-listed company were up 3.9 per cent to 16.14 euros at 0729 GMT.
The company recalled millions of breathing devices and ventilators used to treat sleep apnea in 2021 because foam used to dampen noise from the devices might degrade and become toxic, carrying potential cancer risks.
Fears of large litigation bills have since wiped 70 percent off Philips' market value.
The economic damages claim was made by people, hospitals and health plans who say they suffered economic losses when the millions of machines were recalled.

Read also: Philips respiratory devices recall classified as most serious by USFDA

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News